Taylor Frigon Capital Management’s Apyx Medical APYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.53M Sell
414,559
-23,402
-5% -$87.5K 0.87% 67
2025
Q4
$1.53M Sell
437,961
-32,691
-7% -$114K 0.78% 76
2025
Q3
$1.01M Sell
470,652
-8,252
-2% -$17.5K 0.5% 87
2025
Q2
$1.08M Sell
478,904
-34,761
-7% -$48.9K 0.57% 86
2025
Q1
$704K Sell
513,665
-32,083
-6% -$44.2K 0.42% 90
2024
Q4
$862K Sell
545,748
-51,128
-9% -$71.5K 0.44% 90
2024
Q3
$740K Sell
596,876
-43,690
-7% -$55.2K 0.37% 86
2024
Q2
$858K Buy
640,566
+2,856
+0.4% +$4.21K 0.41% 83
2024
Q1
$867K Sell
637,710
-1,255
-0.2% -$2.67K 0.41% 81
2023
Q4
$1.67M Buy
638,965
+17,818
+3% +$43.1K 0.84% 47
2023
Q3
$1.99M Buy
621,147
+85,596
+16% +$399K 1.1% 35
2023
Q2
$2.69M Sell
535,551
-268,879
-33% -$1.36M 1.32% 31
2023
Q1
$2.32M Buy
804,430
+321,239
+66% +$938K 1.27% 29
2022
Q4
$1.13M Sell
483,191
-14,123
-3% -$43.1K 0.64% 72
2022
Q3
$2.23M Buy
497,314
+3,136
+0.6% +$22.5K 1.16% 33
2022
Q2
$2.9M Sell
494,178
-15,916
-3% -$81.7K 1.51% 22
2022
Q1
$3.33M Buy
510,094
+1,514
+0.3% +$14.9K 1.24% 34
2021
Q4
$6.52M Sell
508,580
-65,619
-11% -$918K 2.04% 14
2021
Q3
$7.95M Sell
574,199
-1,090
-0.2% -$11.5K 2.56% 4
2021
Q2
$5.93M Sell
575,289
-36,423
-6% -$361K 1.85% 15
2021
Q1
$5.91M Sell
611,712
-9,344
-2% -$93.5K 1.82% 23
2020
Q4
$4.47M Buy
621,056
+55,442
+10% +$367K 1.47% 36
2020
Q3
$2.66M Buy
565,614
+9,163
+2% +$45.4K 1.17% 42
2020
Q2
$3.09M Buy
556,451
+71,021
+15% +$295K 1.53% 23
2020
Q1
$1.74M Buy
485,430
+66,560
+16% +$447K 1.37% 32
2019
Q4
$3.54M Sell
418,870
-20,978
-5% -$152K 2.44% 3
2019
Q3
$2.98M Sell
439,848
-9,450
-2% -$67.1K 2.15% 5
2019
Q2
$3.02M Buy
449,298
+222,316
+98% +$1.21M 2.1% 7
2019
Q1
$1.43M Buy
+226,982
New +$1.76M 1.11% 41

Other funds holding APYX